DrugPatentWatch Database Preview

PROCARDIA Drug Profile

« Back to Dashboard

Which patents cover Procardia, and what generic alternatives are available?

Procardia is a drug marketed by Pfizer and is included in two NDAs.

The generic ingredient in PROCARDIA is nifedipine. There are thirty-nine drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the nifedipine profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Procardia

A generic version of PROCARDIA was approved as nifedipine by ACTAVIS ELIZABETH on September 20^th, 1990.

Summary for PROCARDIA

US Patents:	0
Applicants:	1
NDAs:	2
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	136
Clinical Trials:	9
Patent Applications:	4,216
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for PROCARDIA
What excipients (inactive ingredients) are in PROCARDIA?	PROCARDIA excipients list
DailyMed Link:	PROCARDIA at DailyMed

See drug prices for PROCARDIA

Recent Clinical Trials for PROCARDIA

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Medical College of Wisconsin	N/A
Icahn School of Medicine at Mount Sinai	Phase 4
High Risk Obstetrical Consultants	Early Phase 1

See all PROCARDIA clinical trials

Pharmacology for PROCARDIA

Drug Class	Dihydropyridine Calcium Channel Blocker
Mechanism of Action	Calcium Channel Antagonists

Paragraph IV (Patent) Challenges for PROCARDIA

Tradename	Dosage	Ingredient	NDA	Submissiondate
PROCARDIA	CAPSULE;ORAL	nifedipine	018482

US Patents and Regulatory Information for PROCARDIA

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pfizer	PROCARDIA	nifedipine	CAPSULE;ORAL	018482-001	Approved Prior to Jan 1, 1982	AB	RX	Yes	Yes
Pfizer	PROCARDIA XL	nifedipine	TABLET, EXTENDED RELEASE;ORAL	019684-002	Sep 6, 1989	AB2	RX	Yes	No
Pfizer	PROCARDIA	nifedipine	CAPSULE;ORAL	018482-002	Jul 24, 1986		DISCN	Yes	No
Pfizer	PROCARDIA XL	nifedipine	TABLET, EXTENDED RELEASE;ORAL	019684-001	Sep 6, 1989	AB2	RX	Yes	No
Pfizer	PROCARDIA XL	nifedipine	TABLET, EXTENDED RELEASE;ORAL	019684-003	Sep 6, 1989	AB2	RX	Yes	Yes

Expired US Patents for PROCARDIA

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pfizer	PROCARDIA	nifedipine	CAPSULE;ORAL	018482-002	Jul 24, 1986
Pfizer	PROCARDIA	nifedipine	CAPSULE;ORAL	018482-001	Approved Prior to Jan 1, 1982
Pfizer	PROCARDIA	nifedipine	CAPSULE;ORAL	018482-002	Jul 24, 1986
Pfizer	PROCARDIA	nifedipine	CAPSULE;ORAL	018482-001	Approved Prior to Jan 1, 1982

International Patents for PROCARDIA

Country	Patent Number	Estimated Expiration
Poland	89025
Austria	A723072
Belgium	712483
Netherlands	6803501
Malaysia	7800003
German Democratic Republic	99729